Elutia (ELUT) Enterprise Value (2019 - 2026)
Elutia (ELUT) reported Enterprise Value of -$28.5 million for Q1 2026, down 64.12% on a YoY basis from -$79.4 million in Q1 2025, and up 21.63% sequentially from -$36.4 million in Q4 2025.
Elutia (ELUT) Enterprise Value (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Enterprise Value data on file, last reported at -$28.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 64.12% year-over-year to -$28.5 million; the trailing twelve-month figure through Mar 2026 stood at -$28.5 million (down 64.12% YoY), and the FY2025 full-year result was -$36.4 million, down 174.57% from the prior year.
- Enterprise Value rose to -$28.5 million in Q1 2026, from -$36.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.7 million in Q3 2025 to a low of -$36.4 million in Q4 2025.
- A 5-year average of -$16.7 million and a median of -$16.5 million in 2022 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 81.66% in 2025, while the deepest fall reached 174.57% in 2025.
- Tracing ELUT's Enterprise Value over 5 years: stood at -$17.0 million in 2022, then slipped by 13.46% to -$19.3 million in 2023, then jumped by 31.32% to -$13.2 million in 2024, then slumped by 174.57% to -$36.4 million in 2025, then increased by 21.63% to -$28.5 million in 2026.
- Business Quant data shows ELUT's Enterprise Value at -$28.5 million in Q1 2026, -$36.4 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -3.09 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn | -28.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.49 Mn |
| Dec 31, 2025 | -36.35 Mn |
| Sep 30, 2025 | -4.72 Mn |
| Jun 30, 2025 | -8.50 Mn |
| Mar 31, 2025 | -17.36 Mn |
| Dec 31, 2024 | -13.24 Mn |
| Sep 30, 2024 | -25.74 Mn |
| Jun 30, 2024 | -18.19 Mn |
| Mar 31, 2024 | -12.55 Mn |
| Dec 31, 2023 | -19.28 Mn |
| Sep 30, 2023 | -14.52 Mn |
| Jun 30, 2023 | -9.30 Mn |
| Mar 31, 2023 | -11.79 Mn |
| Dec 31, 2022 | -16.99 Mn |
| Sep 30, 2022 | -8.10 Mn |
| Jun 30, 2022 | -16.51 Mn |
| Mar 31, 2022 | -22.18 Mn |
| Dec 31, 2021 | -30.43 Mn |
| Sep 30, 2021 | -22.63 Mn |
| Jun 30, 2021 | -28.37 Mn |